Fragments of syndecan-2 having anti-angiogenic activity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 8, 2020
Grant Date -
Nov 9, 2017
app pub date -
Oct 20, 2015
filing date -
Oct 20, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides an anti-angiogenic peptide comprising an amino acid sequence having at least 70% identity to amino acid residues 123-140 of SEQ ID NO 1 or amino acid residues 24-141 of SEQ ID NO 2. The invention also provides nucleic acid constructs encoding such peptides, and vectors and cells comprising such nucleic acid constructs. The invention further provides pharmaceutical compositions comprising the peptides or nucleic acid constructs of the invention, and the use of peptides, nucleic acid constructs or pharmaceutical compositions of the invention to treat diseases associated with angiogenesis.10
First Claim
Other Claims data not available
Family
International Classification(s)
- 2015 Application Filing Year
- A61K Class
- 16157 Applications Filed
- 11882 Patents Issued To-Date
- 73.55 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 5 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Mar 8, 2028 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Mar 8, 2032 |
